Histopathological features of asymmetric lacrimal gland enlargement in patients with thyroid eye disease
Thyroid Research volume 16, Article number: 32 (2023)
Lacrimal gland enlargement can be a feature of thyroid eye disease (TED). Unilateral or asymmetric lacrimal gland enlargement is poorly described and may impede diagnosis. We present the histological and clinical findings of four patients with asymmetric lacrimal gland enlargement.
A retrospective case note review was performed for patients over two tertiary orbital clinics (Royal Adelaide Hospital, South Australia and the Sussex Eye Hospital, Brighton, United Kingdom) presenting with an asymmetrical lacrimal gland enlargement with a background of TED that underwent biopsy to exclude alternate diagnoses. Baseline data was collected for each patient and histopathological images and reports were reviewed.
All four patients were hyperthyroid at time of lacrimal gland biopsy. Biopsy demonstrated nonspecific, lymphoid aggregates, typically of B cell type, with no diagnostic findings to support lymphocyte clonality or IgG4-related disease. One biopsy specimen demonstrated evidence of some fibrosis.
Asymmetrical lacrimal gland enlargement can occur as part of the TED spectrum but may require biopsy to exclude alternate pathology. Histology demonstrates a non-specific lymphocytic infiltrate.
Thyroid eye disease (TED) is the commonest cause of orbital inflammation in adults. It can result in expansion and fibrosis of the extraocular muscles and orbital fat . Radiological evidence of symmetrical lacrimal gland enlargement secondary to TED has been demonstrated, although asymmetric lacrimal enlargement is atypical and poorly described in the literature [2,3,4,5].
The purpose of this study is to report on the histopathological findings of lacrimal gland biopsies in patients with asymmetric lacrimal gland enlargement.
A retrospective review of clinical case notes was performed for all patients presenting to two units (Royal Adelaide Hospital, South Australia and the Sussex Eye Hospital, United Kingdom) between the years 2013 to 2020. Inclusion criteria included patients with known thyroid dysfunction, upper eyelid retraction and/or lid lag in keeping with thyroid eye disease, clinical and/or radiological findings of lacrimal gland enlargement, magnetic resonance imaging (MRI) of the orbits and subsequent lacrimal gland biopsy and serological investigations (eg serum immunoglobulin subclasses) to exclude concurrent disease.
Baseline data for each patient was collected including age, sex, ocular comorbidity, laterality, ophthalmic findings, and histopathological findings. Clinical Activity Score (CAS) was obtained for the patient’s initial presentation. The CAS evaluates inflammatory signs and symptoms that are often characteristic of active TED.
Ethical approval for this study was not required as per the Human Research Authority (HRA) online decision-making tool. Informed consent was provided by each patient for the procedure and use of clinical information.
Four patients were identified through case note review (Table 1). The mean age of the patients at time of biopsy was 58 years and 9 months (Range of 42–68). Three patients were female.
Three of the four patients presented with upper lid retraction. All four patients had inactive disease. Other common presentation features included lid lag and proptosis. MRI had been requested as routine baseline imaging of the orbital contents.
All patients were biochemically hyperthyroid and demonstrated asymmetrical lacrimal gland enlargement on MRI (Fig. 1 a, b, c, d).
Histopathological analysis of lacrimal gland biopsy specimens showed nonspecific chronic inflammation composed largely of B lymphocytes in all four cases (Figs. 2, 3, 4). Only one case demonstrated some mild fibrosis in the biopsy sample (Fig. 5). Features suggestive of IgG4-related disease were absent and clonality studies negative in all cases.
Lacrimal gland enlargement is a common finding in TED and particularly in the active stage of the disease [4, 6, 7]. Asymmetric lacrimal gland enlargement on the background of thyroid eye disease is atypical and warrants further investigation given the possibility of malignancy and other inflammatory diseases. Ishikawa et al. presented a series of 16 patients with TED and asymmetrical lacrimal enlargement. Biopsies on 9 patients revealed disease entities other than thyroid eye disease such as IgG4-related disease, sarcoidosis and MALT lymphoma . The potential for malignant and severe inflammatory disease means the threshold for biopsy should be low when faced with asymmetrical lacrimal gland enlargement.
Radiological findings may assist the decision-making regarding biopsy of the lacrimal gland. Epithelial neoplasms predominantly involve the orbital lobe whilst inflammatory and lymphoproliferative lesions tend to involve both the orbital and palpebral lobes . Lymphoproliferative disease may also cause bony scalloping, which is generally not seen with inflammatory lesions . Diffusion-weighted imaging (DWI) can be informative: typically the apparent diffusion coefficient (ADC) of the lacrimal gland is low in lymphoma but may be high in TED when compared to healthy controls [9, 10]. The ADC of the lacrimal gland also has a high predictive value to determine active compared to inactive TED. Lacrimal gland features on MRI may assist in staging TED. The signal intensity ratio of the lacrimal gland to the ipsilateral temporal muscle on fat suppressed T2 weighted MRI imaging has shown promise in staging active TED . Patients with active TED demonstrate a higher signal intensity ratio (SIR) of the lacrimal gland to the ipsilateral temporal muscle compared against patients with inactive TED. Clinical features and a careful history may also aid the decision on whether to biopsy the lacrimal gland. Lacrimal gland prolapse is also more likely in active thyroid eye disease [6, 12]. However, the presence of a prolapsed lacrimal gland may make clinical judgement of an enlarged lacrimal gland more difficult clinically and therefore radiological measurements are required.
Previously reported lacrimal gland histopathological findings in TED have also shown nonspecific inflammatory cell infiltration with and without fibrosis [3, 13, 14]. Of the patients with nonspecific dacryoadenitis in the Ishikawa et al. series, inflammatory cells were present with a small amount of fibrotic change in all seven patients and two patients demonstrated germinal centres . Yahalomi et al. described a case of asymmetric lacrimal gland enlargement in a patient with thyroid eye disease with histopathology demonstrating periacinar lymphocytic infiltration . Khu et al. also presented a case report of asymmetric lacrimal gland enlargement in the setting of thyroid eye disease with biopsy showing a mild chronic inflammatory infiltrate composed of plasma cells . The normal lacrimal gland becomes increasingly fibrotic with age . The oldest patient at time of biopsy (68) in our series was the only biopsy specimen to demonstrate fibrosis; it is uncertain if this derives from age or TED chronicity. The residual inflammation present in the biopsies may be an indicator of grumbling inflammation despite all four patients being clinically inactive. Although not present in our series, germinal centres have previously been described in TED-related lacrimal gland enlargement . This finding is also consistent with follicular type idiopathic orbital inflammation (IOI) [16, 17].
These nonspecific histological changes, to some extent, diagnoses thyroid eye disease by exclusion, given the lack of a specific histopathological marker, although there remains the possibility of other concurrent, non-specific, diseases such as idiopathic dacryoadenitis that tend to present unilaterally.
All four patients in the present study were hyperthyroid which contrasts with previous studies which have shown asymmetric TED clinical presentations predominantly in euthyroid or hypothyroid disease states [3, 14, 18, 19]. Fourteen of the sixteen patients analysed in the Ishikawa et al. series on asymmetrical lacrimal gland enlargement were euthyroid . In Eckstein et al.’s study comparing TED clinical symptoms in hyperthyroid patients versus hypothyroid and euthyroid patients, the authors postulated that monosymptomatic and asymmetrical manifestations in euthyroid patients may lead to diagnostic difficulty, increasing the use of imaging by clinicians to confirm diagnosis. Sub-clinical enlargement of the lacrimal gland may therefore be revealed more often in euthyroid and hypothyroid patients through imaging .
There are several limitations to this study. Firstly, the retrospective and non-comparative design limit inferences that can be drawn. Secondly, a standard set of immunohistochemical testing was not undertaken due to the retrospective and multi-centre nature of the study. Finally, we have included a small number of patients, although this may reflect the relatively uncommon nature of TED-related, asymmetric lacrimal gland enlargement.
This study confirms that those patients with lacrimal gland enlargement presumed secondary to TED typically show nonspecific chronic inflammatory changes on histopathological analysis. Lacrimal gland biopsy is prudent given concurrent malignant or inflammatory disease is possible with asymmetrical enlargement although radiological imaging modalities of the lacrimal gland show promise in diagnosing active TED.
Availability of data and materials
All data is made available in the manuscript.
Dolman PJ. Grading severity and activity in thyroid eye disease. Ophthal Plast Reconstr Surg. 2018;34(4S):S34–40.
Huh H-D, Kim J-H, Kim S-J, Yoo J-M, Seo S-W. The change of lacrimal gland volume in korean patients with thyroid-associated ophthalmopathy. Korean J Ophthalmol. 2016;30(5):319.
Ishikawa E, Takahashi Y, Valencia MaRP, Ana-Magadia MG, Kakizaki H. Asymmetric lacrimal gland enlargement: an indicator for detection of pathological entities other than thyroid eye disease. Graefes Arch Clin Exp Ophthalmol. 2019;257(2):405–11.
Bingham CM, Harris MA, Realini T, Nguyen J, Hogg JP, Sivak-Callcott JA. Calculated computed tomography volumes of lacrimal glands and comparison to clinical findings in patients with thyroid eye disease. Ophthal Plast Reconstr Surg. 2014;30(2):116–8.
Harris MA, Realini T, Hogg JP, Sivak-Callcott JA. CT dimensions of the lacrimal gland in graves orbitopathy. Ophthal Plast Reconstr Surg. 2012;28(1):69–72.
Gao Y, Chang Q, Li Y, Zhang H, Hou Z, Zhang Z, et al. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study. BMC Ophthalmol. 2022;22(1):66.
Byun JS, Moon NJ, Lee JK. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy. Graefes Arch Clin Exp Ophthalmol. 2017;255(2):413–20.
Gao Y, Moonis G, Cunnane ME, Eisenberg RL. Lacrimal Gland Masses. Am J Roentgenol. 2013;201(3):W371–81.
Li X, Wu X, Qian J, Yuan Y, Wang S, Ye X, et al. Differentiation of lacrimal gland tumors using the multi-model MRI: classification and regression tree (CART)-based analysis. Acta Radiol. 2021: 028418512110210.
Razek A, El-Hadidy EM, Moawad ME-S, El-Metwaly N, El-hamid El-Said AA. Assessment of lacrimal glands in thyroid eye disease with diffusion-weighted magnetic resonance imaging. Pol J Radiol. 2019;84:142–146.
Hu H, Xu X-Q, Wu F-Y, Chen H-H, Su G-Y, Shen J, et al. Diagnosis and stage of Graves’ ophthalmopathy: Efficacy of quantitative measurements of the lacrimal gland based on 3-T magnetic resonance imaging. Exp Ther Med. 2016;12(2):725–9.
Gagliardo C, Radellini S, Morreale Bubella R, Falanga G, Richiusa P, Vadalà M, et al. Lacrimal gland herniation in Graves ophthalmopathy: a simple and useful MRI biomarker of disease activity. Eur Radiol. 2020;30(4):2138–41.
Yahalomi T, Pikkel J, Arnon R, Soikher E, Rubinov A. Isolated lacrimal gland enlargement in thyroid-related orbitopathy. Case Rep Ophthalmol. 2021;12(1):142–5.
Khu J, Freedman KA. Lacrimal gland enlargement as an early clinical or radiological sign in thyroid orbitopathy. Am J Ophthalmol Case Rep. 2017;5:1–3.
Obata H, Yamamoto S, Horiuchi H, Machinami R. Histopathologic study of human lacrimal gland. Ophthalmology. 1995;102(4):678–86.
Guo J, Qian J, Zhang R. Histopathology and immunohistochemical profile in idiopathic dacryoadenitis. Curr Eye Res. 2012;37(5):365–71.
Mombaerts I, Bilyk JR, Rose GE, McNab AA, Fay A, Dolman PJ, et al. Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified delphi approach. JAMA Ophthalmol. 2017;135(7):769.
Eckstein AK, Losch C, Glowacka D, Schott M, Mann K, Esser J, et al. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Br J Ophthalmol. 2009;93(8):1052–6.
Ponto KA, Binder H, Diana T, Matheis N, Otto AF, Pitz S, et al. Prevalence, phenotype, and psychosocial well-being in euthyroid/hypothyroid thyroid-associated orbitopathy. Thyroid. 2015;25(8):942–8.
There were no sources of funding for this research.
Ethics approval and consent to participate
Need for Ethics approval was waived after use of the NHS Health Research Authority’s Decision-Making Tool.
Consent for publication
Consent for publication was obtained for all patients involved in this study.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Gounder, P., Oliphant, H., Juniat, V. et al. Histopathological features of asymmetric lacrimal gland enlargement in patients with thyroid eye disease. Thyroid Res 16, 32 (2023). https://doi.org/10.1186/s13044-023-00174-4